Product NDC: | 66312-110 |
Proprietary Name: | Oraqix |
Non Proprietary Name: | lidocaine and prilocaine |
Active Ingredient(s): | 25; 25 mg/g; mg/g & nbsp; lidocaine and prilocaine |
Administration Route(s): | PERIODONTAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66312-110 |
Labeler Name: | DENTSPLY Pharmaceutical |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021451 |
Marketing Category: | NDA |
Start Marketing Date: | 20040102 |
Package NDC: | 66312-110-20 |
Package Description: | 20 APPLICATOR in 1 CARTON (66312-110-20) > 1 CARTRIDGE in 1 APPLICATOR > 1.7 g in 1 CARTRIDGE |
NDC Code | 66312-110-20 |
Proprietary Name | Oraqix |
Package Description | 20 APPLICATOR in 1 CARTON (66312-110-20) > 1 CARTRIDGE in 1 APPLICATOR > 1.7 g in 1 CARTRIDGE |
Product NDC | 66312-110 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lidocaine and prilocaine |
Dosage Form Name | GEL |
Route Name | PERIODONTAL |
Start Marketing Date | 20040102 |
Marketing Category Name | NDA |
Labeler Name | DENTSPLY Pharmaceutical |
Substance Name | LIDOCAINE; PRILOCAINE |
Strength Number | 25; 25 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |